跳至主要内容
临床试验/NCT05527977
NCT05527977已完成不适用

Pilot Demonstration for Physician Compensation Incentives to Improve Diagnostic Specificity in Clinical Documentation

Rush University Medical Center2 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2022年9月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
32
试验地点
2
主要终点
Change in Clinical Documentation

研究概览

简要总结

Clinical documentation which omits significant medical details negatively affects communication among physicians and impedes the diagnostic process. Clinical documentation may be improved by using compensation incentives. Therefore, compensation incentives are a compelling mechanism to promote documentation of significant medical details to improve the diagnostic process.

The investigators' proposed project will use physician compensation incentives to improve documentation of clinically significant details for six common diagnoses in outpatient general internal medicine. The investigators will choose clinically significant details which more accurately represent patient complexity, improve the diagnostic process, and have potential to improve patient outcomes. To determine whether compensation incentives improve documentation of clinically significant details, the investigators will compare physicians' baseline documentation to incentivized documentation. The purpose of the investigators' project is to improve communication of clinically significant diagnostic information among physicians, thereby reducing suboptimal treatment plans, overuse, medical error, and cognitive burden upon physicians.

详细描述

Implementation: The investigators' proposed project will use physician compensation incentives to improve documentation of clinically significant details for six common diagnoses in outpatient general internal medicine. The purpose of the program is to improve clinical documentation in order to reduce misdiagnosis and medical errors. The investigators will invite 30-35 primary care physicians in internal medicine and family medicine within Rush University Medical Group to participate. The investigators will review participants' office visit notes for clinical documentation that meets pre-specified criteria. The investigators anticipate that physicians will receive a $5-$10 compensation bonus for each office visit progress note that meets clinical criteria. The investigators' program will be in effect for 3-months. The average performing physician is expected to receive $650-$700 in compensation incentives over the entire 3-month period (higher performing physicians expected to earn $1,000 or above for superior performance).

Approach: To determine whether compensation incentives improve documentation of clinically significant details, the investigators will compare physicians' baseline documentation (during a 6-week run-in period) to incentivized documentation (a 3-month period when physicians will receive compensation incentives for their clinical documentation). Two research assistants will perform retrospective chart review and audits of office visit progress notes. Notes will be scored for whether documentation includes pre-specified clinically significant information. For example, if a patient has had a Deep Vein Thrombosis (DVT), the investigators would assess whether the month of onset of the DVT and duration of anticoagulation therapy was documented in the note. The investigators anticipate that compensation incentives will improve physicians' clinical documentation of clinically significant medical details. The investigators' results will be reported in aggregate at the physician-level.

Participation: 30-35 physicians will be invited to participate in both the incentives program and analysis comparing baseline performance to incentivized performance. If a physician opts out of the analysis, that participant will not be eligible for compensation incentives. The investigators chose a sample of 30-35 physicians so that the study has enough power to detect a significant difference in performance in clinical documentation during the incentivized period compared to baseline.

Risks to patients: The investigators will use patient-level data as covariates in the analysis. The investigators' analysis will occur in a similar fashion as other retrospective studies, whereby patient-level information will be used from individual office visits in the analysis. Patient-level information will be de-identified as quickly as possible and precautions will be made to keep patient and physician-level data secure.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Sequential
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

盲法说明

The investigators have two research assistants who will perform retrospective chart review. The participants will not be informed of the incentive used (i.e., participants will now know whether the investigators have control/experimental group nor pre/post design)

入排标准

性别
All
接受健康志愿者

入选标准

  • Physicians, PA's, and NP's at any of 8 pre-selected Rush practice sites.
  • Clinical FTE >40%

排除标准

  • Physicians, PA's, or NP's who have a significant change in clinical FTE or scheduled patient volume during the intervention
  • Equitable considerations include: Enrolling all clinicians (MD/DO, PA, NP) at each practice. Physicians with <40% FTE are expected to be eligible to earn low amounts of income from the program (estimated around less than $300 before taxes over 3-month period), hence the investigators will exclude them due to poor motivating force of this total incentive and adverse impacts on the statistical analysis.

结局指标

主要结局

Change in Clinical Documentation

时间窗: Change from baseline documentation over 6 a week period to incentivized documentation over a 12 week period.

2 Research assistants will use a binary scoring system for whether or not the documentation for a given diagnosis of interest includes pre-specified diagnostic information at the visit level. The investigators will create this binary scoring system a priori using evidence-based literature about common documentation errors and shortcomings related to the diagnostic process

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David S. Burstein

Assistant Professor

Rush University Medical Center

研究点 (2)

Loading locations...

相似试验